Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053593 · ClinicalTrials.gov registry record
Ketostix® and Keto-Diastix® Performance Study
A clinical trial of Urinalysis, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- 126
- Enrollment target
- 1
- Study location
NCT06053593: Completed study of Urinalysis, sponsored by Ascensia Diabetes Care.
NCT06053593 is a study of Urinalysis that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 126 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053593, a study of Urinalysis, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. The products are: Ketostix and Keto-Diastix.
Primary Outcome
Number of Participants with results from self collected urine that are within one color block of reference analyzer
Conditions Studied
Interventions
- DEVICE Testing of self collected urine
- DEVICE Labeling Evaluation
- DEVICE Urine Control testing
Study Locations (1)
Maryland
- University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2023-11-30 |
What the finished NCT06053593 record still lists
NCT06053593 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Urinalysis appearing as the primary indexed condition, and to 3 interventions - of which Testing of self collected urine is the first listed.
NCT06053593 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06053593 about?
NCT06053593 is a clinical study titled "Ketostix® and Keto-Diastix® Performance Study". Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. The products are: Ketostix and Keto-Diastix.
What is the current status of trial NCT06053593?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2023-07-24. Estimated completion is 2023-11-30.
What conditions does trial NCT06053593 study?
This clinical trial studies the following conditions: Urinalysis.
What interventions are being tested in trial NCT06053593?
The interventions under investigation include: Testing of self collected urine (DEVICE), Labeling Evaluation (DEVICE), Urine Control testing (DEVICE).
Who is sponsoring clinical trial NCT06053593?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053593 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI